Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News PerkinElmer partnership to focus on GPCR research

PerkinElmer partnership to focus on GPCR research

17th March 2009

PerkinElmer has announced a new partnership with a Korean university that could lead to wider use of its aequorin assay technology.

The company has struck a deal with Sangmyung University in the republic that will focus on drug discovery research using PerkinElmer’s AequoScreen system.

It is hoped that the aequorin assay will be used in G-protein coupled receptor (GPCR) research – a field where it is thought up to 30 per cent of addressable diseases could be treated should the right product be found.

Commenting on the partnership, PerkinElmer president Dr Richard M Eglen said the scope for GPCR research was behind the decision to invest in further projects.

"We are very pleased to be working with the distinguished faculty of Sangmyung University in providing our AequoScreen technology in support of their Korea-wide GPCR screening campaign implementation," he added.

Last week, PerkinElmer announced the launch of its Labworkstm 6.1 laboratory information management system.
ADNFCR-1050-ID-19077844-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.